There are a lot of quality shares for investors to choose from on the ASX 200 index.

In order to narrow things down for investors, listed below are three ASX 200 shares that are rated highly by analysts and could be quality buy and hold options.

Here’s what you need to know about them:

Goodman Group (ASX: GMG)

The first ASX 200 share that could be a great buy and hold option is Goodman Group. It is a leading integrated commercial and industrial property group that owns a high quality portfolio of assets. Given that a good portion of its portfolio has exposure to structural tailwinds such as ecommerce and the digital economy, they look likely to be in demand with customers for a long time to come. This should be supportive of strong rental income and distribution growth over the next decade.

Citi is a fan of Goodman and has a buy rating and $24.00 price target on its shares.

Ramsay Health Care Limited (ASX: RHC)

Another ASX 200 share to consider as a buy and hold investment is Ramsay Health Care. It is a leading private healthcare company with operations across the world. After struggling during the pandemic, Ramsay has started to bounce back and looks set to benefit from a backlog in surgeries in the near term. Looking further ahead, the company appears well-placed for long term growth thanks to increasing demand for healthcare services due partly to ageing populations and increased chronic disease.

Morgans is positive on the company and has an add rating and $74.41 price target on its shares.

ResMed Inc. (ASX: RMD)

A final ASX 200 share to buy and hold could be ResMed. It is a medical device company with a focus on the sleep treatment market. Thanks to its industry-leading products, wide distribution network, and successful acquisitions, ResMed has been growing at a solid rate for years. The good news is that thanks to its significant market opportunity and the growing prevalence of sleep disorders, it has been tipped to continue this trend long into the future.

Citi is also bullish on ResMed and has a buy rating and $39.00 price target on its shares.

The post 3 excellent ASX 200 shares to buy and hold for a decade: analysts appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• How to generate passive income the Warren Buffett way with ASX shares
• 2 ASX 200 stocks on the move following earnings updates
• Why experts say these ASX 200 blue chip shares are buys
• This ASX 200 share is one of my top ideas to rake it in on a recovery
• How do I cash in my Newcrest shares if US giant Newmont takes over?

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool Australia has recommended Goodman Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/fPb9o2u

• Stock Market